Related Experiment Video
Updated: May 21, 2025

07:51
Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
5.9K
IL7-IL7R Interaction Mediates Fibroblast-Driven Macrophage-to-Osteoclast Differentiation in Periodontitis
Pengjie Huang1, Li Gao1, Jiezhong Guan1
1Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, People's Republic of China.
Journal of Inflammation Research
|May 19, 2025
Summary
This study identifies Interleukin-7 Receptor-positive (IL7R+) macrophages as key players in periodontitis bone loss. Targeting the IL7/IL7R pathway offers a promising therapeutic strategy to reduce bone resorption in periodontitis.
Area of Science:
- Immunology
- Oral Biology
- Cell Biology
Background:
- Periodontitis is a chronic inflammatory disease leading to alveolar bone destruction.
- Macrophage subsets play critical roles in the pathogenesis of periodontitis, but specific osteoclastogenic populations remain poorly defined.
Purpose of the Study:
- To identify osteoclastogenic macrophage subsets in periodontitis.
- To elucidate the regulatory mechanisms driving their osteoclastogenic potential.
- To explore potential therapeutic targets for periodontitis-associated bone loss.
Main Methods:
- Integrated single-cell RNA sequencing from human and murine periodontitis datasets.
- Functional enrichment, cell-cell communication, and machine learning analyses.
- In vitro and in vivo validation using assays like ELISA, TRAP staining, micro-CT, qPCR, flow cytometry, and immunofluorescence.
Main Results:
- Identified Interleukin-7 Receptor-positive (IL7R+) macrophages as having significant osteoclast differentiation potential.
- The Interleukin-7 (IL7)/IL7R signaling axis was confirmed to drive osteoclast differentiation.
- IL7R+ macrophages increased in periodontitis, and targeting IL7/IL7R signaling mitigated bone resorption.
Conclusions:
- IL7R+ macrophages are identified as potential osteoclast precursors in periodontitis.
- The IL7/IL7R signaling pathway is a critical therapeutic target for periodontitis.
- Inhibition of IL7R presents a potential strategy to prevent bone loss in periodontitis.

